Amanda Copeland
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 20
-
- Histone Deacetylase Inhibitors Research 13
- Protein Degradation and Inhibitors 5
- Ubiquitin and proteasome pathways 2
- Co-authors
- Anas Younes (33 shared papers)Sattva S. Neelapu (13 shared papers)Michelle A. Fanale (15 shared papers)Yasuhiro Oki (12 shared papers)Jorge Romaguera (12 shared papers)Larry W. Kwak (7 shared papers)Luis Fayad (11 shared papers)Daniela Buglio (7 shared papers)
- Journals
- Blood (14 papers)Journal of Clinical Oncology (6 papers)Clinical Cancer Research (2 papers)The Lancet Oncology (2 papers)Current Opinion in Oncology (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Amanda Copeland
36 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 72
- Pathology and Forensic Medicine 516
- Genetics 276
- Oncology 554
- Hematology 99
- Molecular Biology 510
Countries citing papers authored by Amanda Copeland
This map shows the geographic impact of Amanda Copeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Copeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Copeland more than expected).
Fields of papers citing papers by Amanda Copeland
This network shows the impact of papers produced by Amanda Copeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Copeland. The network helps show where Amanda Copeland may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Copeland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 158 | |
| 2 | 2016 | 157 | |
| 3 | 2012 | 134 | |
| 4 | 2012 | 119 | |
| 5 | 2013 | 85 | |
| 6 | 2017 | 82 | |
| 7 | 2015 | 68 | |
| 8 | 2009 | 66 | |
| 9 | 2011 | 56 | |
| 10 | 2012 | 54 | |
| 11 | 2016 | 40 | |
| 12 | 2010 | 29 | |
| 13 | 2009 | 24 | |
| 14 | 2017 | 23 | |
| 15 | 2011 | 17 | |
| 16 | 2011 | 13 | |
| 17 | 2009 | 12 | |
| 18 | 2010 | 12 | |
| 19 | 2012 | 12 | |
| 20 | 2011 | 10 |
About Amanda Copeland
Amanda Copeland is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Oncology, Genetics and Neurology, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (20 papers), Histone Deacetylase Inhibitors Research (13 papers), Chronic Lymphocytic Leukemia Research (8 papers), Viral-associated cancers and disorders (7 papers), Protein Degradation and Inhibitors (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Ubiquitin and proteasome pathways (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (516 citations), Genetics (276 citations), Oncology (554 citations), Hematology (99 citations) and Molecular Biology (510 citations). Amanda Copeland has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Anas Younes, Sattva S. Neelapu, Michelle A. Fanale, Yasuhiro Oki, Jorge Romaguera, Larry W. Kwak, Luis Fayad, Daniela Buglio, Frederick Hagemeister and Peter McLaughlin. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, The Lancet Oncology and Current Opinion in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.